MYCITRACIN Drug Patent Profile
✉ Email this page to a colleague
When do Mycitracin patents expire, and what generic alternatives are available?
Mycitracin is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in MYCITRACIN is bacitracin; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Additional details are available on the bacitracin; neomycin sulfate; polymyxin b sulfate profile page.
Summary for MYCITRACIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 20 |
Patent Applications: | 2,723 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYCITRACIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYCITRACIN
US Patents and Regulatory Information for MYCITRACIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | MYCITRACIN | bacitracin; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 061048-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |